Document is current
Any future updates will be listed below
-
Authors
Lau, Joseph
Pan, Jinhe
Rousseau, Etienne
Uribe, Carlos F.
Seelam, Sudhakara Reddy
Sutherland, Brent W.
Perrin, David M.
Lin, Kuo-Shyan
Bénard, François https://orcid.org/0000-0001-7995-3581
-
Funding
Funding for this research was provided by:
Canadian Institutes of Health Research (PPP-141710)
Leading Edge Endowment Fund
- License Information
-
More Information
Article History
Received: 30 December 2019
Accepted: 18 February 2020
First Online: 19 March 2020
Ethics approval
: All applicable institutional and/or national guidelines for the care and use of animals were followed, and the study protocol was approved by the institutional Research Ethics Board.
: Not applicable.
: Drs. Jinhe Pan, David M. Perrin, Kuo-Shyan Lin, and François Bénard are co-inventors of a patent that covers [<sup>18</sup>F]AmBF<sub>3</sub>-TATE and the BF<sub>3</sub> platform, and are shareholders of Alpha-9 Theranostics, which holds a license to the technology.
